- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06714994
Effect of Spectacle Distribution to Myopic Secondary School Students in Rural Communities of Liaoning Province on Communities Academic High School Enrolment
December 3, 2024 updated by: He Eye Hospital
To determine whether provision of free spectacles to rural-dwelling Chinese secondary school students with visually-significant refractive error, together with a teacher-based incentive to promote their use, increases the proportion of children going on to academic high school, as opposed to dropping out or pursuing a vocational track.
Study Overview
Detailed Description
The investigators propose in the current trial to significantly expand the evidence base for spectacle distribution as the most-effective health intervention to improve educational opportunities for China's under-served rural children and adolescents by assessing impact on school attainment.
Study Type
Interventional
Enrollment (Estimated)
1980
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Guanghao Qin
- Phone Number: 0086-18842664420
- Email: qinguanghao@hsyk.com.cn
Study Contact Backup
- Name: Jiayan Chen
- Phone Number: 0086-18304019060
- Email: chenjiayan@hsyk.com.cn
Study Locations
-
-
-
Shenyang, China, 110034
- He Eye Specialist Hospital
-
Contact:
- Guanghao Qin
- Email: qinguanghao@hsyk.com.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Year 1 students (about 12-15 years old) from schools in county-level cities and below in Liaoning Province
- Uncorrected (self-glasses) visual acuity of ≤6/12 in both eyes
- Refractive error meets cut-offs shown to be associated with significantly greater improvement in visual acuity when corrected7 (myopia ≤-0.75 diopters (D, or astigmatism (non-spherical refractive error) ≥1.00 D
- Best corrected visual acuity ≥6/7.5 in either eye
Exclusion Criteria:
- Hyperopia ≥2.00 D
- Presence of visually-significant ocular condition besides refractive error
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study group
Children at Intervention schools will receive free spectacles of a design they select, based on the child's measured refractive power and dispensed at school by the teacher.
All students will be advised to wear glasses as much as possible during the study to ensure clear vision.
|
Children will receive free spectacles
|
|
No Intervention: Control group
Children at Control schools will receive a glasses prescription and letter to the parents informing them of the refractive status of their child, with free glasses provided only at the end of the trial.
Service offered to the Control group exceeds standard care, in that no school-based programs of vision screening and refraction currently exist in the study area, or in most of rural China.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attendance at academic high school
Time Frame: In July following completion of Year 3 of Middle School. This occurs after 32 months of participant followup.
|
This will be assessed by systematically contacting parents, teachers and students to ascertain enrolment status, which REAP has used to obtain > 97% follow-up in previous studies of high school accession.
In the event of inconsistent responses, priority will be given to responses of parents, then teachers and finally students
|
In July following completion of Year 3 of Middle School. This occurs after 32 months of participant followup.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression and Anxiety
Time Frame: At baseline and 12 months post-treatment
|
Depression and anxiety score measured with Anxiety Stress Scale (DASS).
The score range for depression, anxiety and stress are 0-42, with higher score indicates more severe mental health problems.
|
At baseline and 12 months post-treatment
|
|
Self Esteem
Time Frame: At baseline and 12 months post-treatment
|
Self-esteem score measured with the Rosenberg Self-esteem Scale.
The scores range from 0-30, with higher scores indicate higher self-esteem.
|
At baseline and 12 months post-treatment
|
|
Progression of Shortsightedness
Time Frame: At baseline and 12 months post-treatment
|
Progression of Shortsightedness will be measured using change in refraction over time
|
At baseline and 12 months post-treatment
|
|
Compliance with spectacle wear
Time Frame: After 12 months of participant followup
|
Actual presence of spectacles on the child's face (rather than having glasses at school)at the time of an unannounced examination.
|
After 12 months of participant followup
|
|
Classroom use of blackboards versus textbooks
Time Frame: After 12 months of participant followup
|
Frequency of blackboard versus textbook use in the major subjects (Maths Chinese, English) on a questionnaire administered to teachers, and answered as "all", "most", "about half", little" or "none" of teaching.
|
After 12 months of participant followup
|
|
Cost effectiveness of intervention.
Time Frame: At study closeout, after 32 months of participant follow up
|
Calculated as ratio of incremental cost to proportion of children who continue to academic high school as opposed to vocational high school or no schooling.
Incremental cost is the difference of costs between implementation of intervention and control, Intervention costs will comprise the screening test glasses (including replacements).
|
At study closeout, after 32 months of participant follow up
|
|
Emotional and behavioral problems
Time Frame: At baseline and 12 months post-treatment
|
Emotional and behavioral problems score using the Strengths and Difficulties Questionnaire (SDQ), with difficulties score ranges from 0 to 40, Prosocial scale ranges from 0-10,with higher score indicates severe mental health and behavioral problems.
|
At baseline and 12 months post-treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Guanghao Qin, He Eye Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997 Jul;38(5):581-6. doi: 10.1111/j.1469-7610.1997.tb01545.x.
- Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43. doi: 10.1016/0005-7967(94)00075-u.
- Ma X, Zhou Z, Yi H, Pang X, Shi Y, Chen Q, Meltzer ME, le Cessie S, He M, Rozelle S, Liu Y, Congdon N. Effect of providing free glasses on children's educational outcomes in China: cluster randomized controlled trial. BMJ. 2014 Sep 23;349:g5740. doi: 10.1136/bmj.g5740.
- Ma Y, Congdon N, Shi Y, Hogg R, Medina A, Boswell M, Rozelle S, Iyer M. Effect of a Local Vision Care Center on Eyeglasses Use and School Performance in Rural China: A Cluster Randomized Clinical Trial. JAMA Ophthalmol. 2018 Jul 1;136(7):731-737. doi: 10.1001/jamaophthalmol.2018.1329.
- Jiang C, Zhu Y, Luo Y, Tan CS, Mastrotheodoros S, Costa P, Chen L, Guo L, Ma H, Meng R. Validation of the Chinese version of the Rosenberg Self-Esteem Scale: evidence from a three-wave longitudinal study. BMC Psychol. 2023 Oct 18;11(1):345. doi: 10.1186/s40359-023-01293-1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2024
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
November 25, 2024
First Submitted That Met QC Criteria
December 3, 2024
First Posted (Estimated)
December 4, 2024
Study Record Updates
Last Update Posted (Estimated)
December 4, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SWISH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Anonymized datasets generated and analyzed during the current study will be made available on reasonable request by the PI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on free spectacles
-
University of California, BerkeleyCarl Zeiss Meditec, Inc.CompletedPresbyopiaUnited States
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknown
-
Johns Hopkins UniversityNational Health and Medical Research Council, AustraliaCompletedAstigmatism | Myopia | HyperopiaChina, India
-
Essilor InternationalQueensland University of TechnologyCompleted
-
Beijing Visionly Plus Eye HospitalHigh Myopia Control Alliance (HIMALAYA); Beijing New Vision Eye HospitalRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterBrien Holden VisionRecruitingBlindness,Visual Impairment, Refractive Error, Cataract, High Myopia, AgingChina
-
Ohio State UniversityNational Eye Institute (NEI)Not yet recruitingVisual Acuity | Refractive Error CorrectionUnited States
-
CooperVision, Inc.CompletedAmetropiaUnited Kingdom
-
Avulux, Inc.Completed